INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2015

High onion intake lowered cancer markers during doxorubicin chemotherapy

A double-blind trial randomized 56 breast cancer patients receiving doxorubicin into groups consuming 100-160 g/day or 30-40 g/day of fresh yellow onion for eight weeks. Participants consuming the higher amount of onion showed significant reductions in carcinoembryonic antigen, cancer antigen-125, and alkaline phosphatase levels compared to the low-onion group (P < 0.05).

Study type
Randomized controlled trial
Who was studied
56 breast cancer patients treated with doxorubicin
What was measured
Tumor markers and hepatic enzymes

THE PAPER

Effects of Fresh Yellow Onion Consumption on CEA, CA125 and Hepatic Enzymes in Breast Cancer Patients: A Double- Blind Randomized Controlled Clinical Trial.

Jafarpour-Sadegh F, Montazeri V, Adili A, Esfehani A, Rashidi MR, Mesgari M, Pirouzpanah S. Asian Pac J Cancer Prev, 2015.

PubMed 26625755 ↗DOI 10.7314/apjcp.2015.16.17.7517 ↗

CancerTop 21: Onions

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.